FUSCO, ALFREDO
 Distribuzione geografica
Continente #
AS - Asia 4.554
NA - Nord America 2.147
EU - Europa 907
SA - Sud America 899
AF - Africa 76
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.592
Nazione #
US - Stati Uniti d'America 2.050
SG - Singapore 2.026
CN - Cina 1.025
BR - Brasile 730
HK - Hong Kong 494
VN - Vietnam 478
FR - Francia 255
KR - Corea 183
NL - Olanda 181
IT - Italia 167
AR - Argentina 64
DE - Germania 61
IN - India 61
BD - Bangladesh 57
GB - Regno Unito 54
FI - Finlandia 43
JP - Giappone 42
EC - Ecuador 37
ID - Indonesia 35
CA - Canada 33
MX - Messico 33
ZA - Sudafrica 25
IL - Israele 22
PL - Polonia 20
CO - Colombia 19
ES - Italia 18
PK - Pakistan 17
SA - Arabia Saudita 16
TR - Turchia 16
VE - Venezuela 15
RU - Federazione Russa 14
MA - Marocco 13
PY - Paraguay 13
SE - Svezia 13
IQ - Iraq 12
UA - Ucraina 11
AT - Austria 10
PH - Filippine 10
PE - Perù 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 7
CL - Cile 7
LT - Lituania 7
PA - Panama 7
UZ - Uzbekistan 7
AU - Australia 6
GR - Grecia 6
NP - Nepal 6
BG - Bulgaria 5
EG - Egitto 5
KE - Kenya 5
LB - Libano 5
PT - Portogallo 5
DZ - Algeria 4
GT - Guatemala 4
HN - Honduras 4
IE - Irlanda 4
JM - Giamaica 4
JO - Giordania 4
PS - Palestinian Territory 4
AZ - Azerbaigian 3
BB - Barbados 3
BE - Belgio 3
BY - Bielorussia 3
CR - Costa Rica 3
GE - Georgia 3
HR - Croazia 3
AO - Angola 2
BH - Bahrain 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CY - Cipro 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GA - Gabon 2
HU - Ungheria 2
IS - Islanda 2
KW - Kuwait 2
KZ - Kazakistan 2
LV - Lettonia 2
MD - Moldavia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
OM - Oman 2
RO - Romania 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CD - Congo 1
Totale 8.578
Città #
Singapore 1.147
Santa Clara 751
Hong Kong 490
Hefei 380
San Jose 236
Beijing 215
Lauterbourg 215
Seoul 179
Ho Chi Minh City 171
Ashburn 161
Hanoi 107
Los Angeles 107
São Paulo 65
Dallas 45
Buffalo 43
Naples 41
Helsinki 40
New York 39
Frankfurt am Main 31
Da Nang 26
Minamishinagawa 24
Orem 21
Rio de Janeiro 19
Belo Horizonte 16
Bengaluru 16
London 16
Warsaw 16
Dhaka 14
Tokyo 14
Biên Hòa 13
Brasília 13
Haiphong 13
Campinas 12
Guayaquil 12
Stockholm 12
Chicago 11
Hải Dương 11
Johannesburg 11
Porto Alegre 11
Quito 11
Atlanta 10
Curitiba 10
Düsseldorf 10
Houston 10
Ninh Bình 10
Phoenix 10
Seattle 10
Brooklyn 9
Ribeirão Preto 9
Amsterdam 8
Bắc Giang 8
Denver 8
Falkenstein 8
Paris 8
Portsmouth 8
Asunción 7
Baghdad 7
Chennai 7
Madrid 7
Milan 7
Poplar 7
Quận Bình Thạnh 7
Caracas 6
Caxias do Sul 6
Jakarta 6
Lahore 6
Phủ Lý 6
Querétaro 6
Quận Phú Nhuận 6
Recife 6
Shanghai 6
Sorocaba 6
Tashkent 6
Buenos Aires 5
Franca 5
Hangzhou 5
Jeddah 5
Manaus 5
Manchester 5
Mexico City 5
Milwaukee 5
Montes Claros 5
Montreal 5
Mumbai 5
New Delhi 5
Nha Trang 5
Piscataway 5
San Francisco 5
Santo André 5
The Dalles 5
Tunis 5
Turin 5
Uberlândia 5
Vienna 5
Vila Velha 5
Ankara 4
Belém 4
Boardman 4
Bogotá 4
Boston 4
Totale 5.156
Nome #
HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas. 87
Point mutation in GRIM-19: a new genetic lesion in Hurthle cell thyroid carcinomas. 85
Genetic ablation of homeodomain-interacting protein kinase 2 selectively induces apoptosis of cerebellar Purkinje cells during adulthood and generates an ataxic-like phenotype 79
Suppression of transformation by inhibition of HMGI-C protein synthesis: regulatory changes of NF-kB and AP-1 transcription factors. 79
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma. 76
HMGA1: a choice of symmetry 75
HMGA2, but not HMGA1, is overexpressed in human larynx carcinomas 74
Altered MicroRNA Expression Profile in Human Pituitary GH Adenomas: Down-Regulation of miRNA Targeting HMGA1, HMGA2, and E2F1 73
High mobility group A1 protein expression reduces the sensitivity of colon and thyroid cancer cells to antineoplastic drugs 72
The impairment of the High Mobility Group A (HMGA) protein function contributes to the anticancer activity of trabectedin. 72
The b-catenin Axis Integrates Multiple Signals Downstream From RET/PTC and Leads to Cell Proliferation. 69
CBX7 gene expression plays a negative role in adipocyte cell growth and differentiation. 67
Loss of the CBX7 protein expression correlates with a more aggressive phenotype in pancreatic cancer 66
Characterization of inflammatory infiltrate of ulcerative dermatitis in C57BL/6NCrl-Tg(HMGA1P6)1Pg mice 65
PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration 63
The role of the suppressor genes and of HMGI proteins. 62
A differential proteomic approach to identify proteins associated with thyroid cell transformation 61
CCDC6 represses CREB1 activity by recruiting histone deacetylase 1 and protein phosphatase 1 57
HMGA1 silencing reduces stemness and temozolomide resistance in glioblastoma stem cells 57
A ceRNA circuitry involving the long noncoding RNA KLHL14-AS, PAX8, and BCL2 drives thyroid carcinogenesis 56
HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs 55
HMGA1-pseudogene overexpression contributes to cancer progression 55
Isolation and functional characterization of peptide agonists of PTPRJ, a tyrosine phosphatase receptor endowed with tumor suppressor activity. 54
Identification and Synthesis of Mycalol Analogues with Improved Potency against Anaplastic Thyroid Carcinoma Cell Lines. 54
Setting up and exploitation of a nano/technological platform for the evaluation of HMGA1b protein in peripheral blood of cancer patients. Nanomedicine. 54
UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas. 54
HIPK2 controls cytokinesis and prevents tetraploidization by phosphorylating histone H2B at the midbody. 53
POZ-, AT-hook-, and Zinc Finger-containing Protein (PATZ) Interacts with Human Oncogene B Cell Lymphoma 6 (BCL6) and Is Required for Its Negative Autoregulation 53
The High Mobility Group A proteins contribute to thyroid cell transformation by regulating miR-603 and miR-10b expression. 52
Setting up and exploitation of a nano/technological platform for the evaluation of HMGA1b protein in peripheral blood of cancer patients. 52
Impairment of the p27kip1 function enhances thyroid carcinogenesis in TRK-T1 transgenic mice 52
Double knock-out of Hmga1 and Hipk2 genes causes perinatal death associated to respiratory distress and thyroid abnormalities in mice 51
In ataxia-teleangiectasia betamethasone response is inversely correlated to cerebellar atrophy and directly to antioxidative capacity. 50
AP-1 compositional changes in transformed thyroid cells: role of fra-1 induction and functional interaction with the HMGI-C gene product. 50
Oncogenic Properties of the Antisense lncRNA COMET in BRAF- and RET-Driven Papillary Thyroid Carcinomas 50
HMGA2 cooperates with either p27 deficiency or Cdk4 mutation in pituitary tumorigenesis. 49
HIPK2 deficiency causes chromosomal instability by cytokinesis failure and increases tumorigenicity 49
Oncogenic alterations in papillary thyroid cancers of young patients. 49
The metallophosphoesterase-domain-containing protein 2 (MPPED2) gene acts as tumor suppressor in breast cancer 49
Pax8 has a critical role in epithelial cell differentiaion, survival and proliferation. 49
miR-155 is positively regulated by CBX7 in mouse embryonic fibroblasts and colon carcinomas, and targets the KRAS oncogene 48
The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteins. 48
The lncRNA RMST is drastically downregulated in anaplastic thyroid carcinomas where exerts a tumor suppressor activity impairing epithelial-mesenchymal transition and stemness 48
UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients 48
Characterization of HMGA1P6 transgenic mouse embryonic fibroblasts 47
PATZ1 is a target of miR-29b that is induced by Ha-Ras oncogene in rat thyroid cells 47
MPPED2 is downregulated in glioblastoma, and its restoration inhibits proliferation and increases the sensitivity to temozolomide of glioblastoma cells 47
PATZ1 interacts with p53 and regulates expression of p53-target genes enhancing apoptosis or cell survival based on the cellular context 46
HMGA and cancer: A review on patent literatures 46
Loss of CCDC6, the first identified RET partner gene, affects pH2AX S139 levels and accelerates mitotic entry upon DNA damage. 46
Tumour Suppressor Role of the CL2/DRO1/CCDC80 Gene in Thyroid Carcinogenesis. 46
Critical role of the high mobility group A proteins in hematological malignancies 45
Identification of HMGA2 inhibitors by AlphaScreen-based ultra-high-throughput screening assays 45
Critical role of HMGA proteins in cancer cell chemoresistance 45
The cl2/dro1/ccdc80 null mice develop thyroid and ovarian neoplasias 45
Restoration of CBX7 expression increases the susceptibility of human lung carcinoma cells to irinotecan treatment 45
Regulation of p27Kip1 protein levels contributes to mitogenic effects of the RET/PTC kinase in thyroid carcinoma cells. 45
Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization. 44
The HMGA1-pseudogene7 shows oncogenic activity in vivo 44
Hmga1/Hmga2 double knock-out mice display a "superpygmy" phenotype 44
Drug-induced inhibition of HMGA and EZH2 activity as a possible therapy for anaplastic thyroid carcinoma 44
The rat tyrosine phosphatase eta increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue. 44
Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas. 44
The highly malignant phenotype of anaplastic thyroid carcinoma cell lines is recessive. 43
Molecular characterization of RET/PTC3; a novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma 43
Deregulation of HMGA1 expression induces chromosome instability through regulation of spindle assembly checkpoint genes 43
Role of Dicer1 in thyroid cell proliferation and differentiation 43
Regulation of microRNA expression by HMGA1 proteins. 42
MIR191 (microRNA 191) 42
Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation. 42
Hmga1null mouse embryonic fibroblasts display downregulation of spindle assembly checkpoint gene expression associated to nuclear and karyotypic abnormalities 42
CBX7 is a tumor suppressor in mice and humans 42
RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma 42
Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation. 42
miR-130b-3p Upregulation Contributes to the Development of Thyroid Adenomas Targeting CCDC6 Gene. 42
MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle 42
PATZ attenuates the RNF4-mediated enhancement of androgen receptor-dependent transcription. 41
The long non-coding RNA RP5-1024C24.1 and its associated-gene MPPED2 are down-regulated in human thyroid neoplasias and act as tumour suppressors 41
TWIST1 plays a pleiotropic role in determining the anaplastic thyroid cancer phenotype. 41
HMGA2 overexpression plays a critical role in the progression of esophageal squamous carcinoma 41
Deregulation of microRNA expression in thyroid neoplasias 40
Enhancer of zeste homolog 2 overexpression has a role in the development of anaplastic thyroid carcinomas. 40
Analysis of UbcH10 expression represents a useful tool for the diagnosis and therapy of astrocytic tumors. 40
Critical role of CCDC6 in the neoplastic growth of testicular germ cell tumors. 40
Chromobox protein homologue 7 protein, with decreased expression in human carcinomas, positively regulates E-cadherin expression by interacting with the histone deacetylase 2 protein. 39
HMGA1-pseudogene expression is induced in human pituitary tumors 39
Loss of one or two PATZ1 alleles has a critical role in the progression of thyroid carcinomas induced by the RET/PTC1 oncogene 39
HMGA1-pseudogene7 transgenic mice develop B cell lymphomas 39
HMGA1 negatively regulates NUMB expression at transcriptional and post transcriptional level in glioblastoma stem cells 39
CBX7 Modulates the Expression of Genes Critical for Cancer Progression 39
The HMGA1 Pseudogene 7 Induces miR-483 and miR-675 Upregulation by Activating Egr1 through a ceRNA Mechanism 39
Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models. 39
HMGA2 cooperates with either p27kip1 deficiency or Cdk4R24C mutation in pituitary tumorigenesis Cell Cycle 39
Structural Model of the hUbA1-UbcH10 Quaternary Complex: In Silico and Experimental Analysis of the Protein-Protein Interactions between E1, E2 and Ubiquitin. 39
Identification of a new pathway for tumor progression: MicroRNA-181b up-regulation and CBX7 down-regulation by HMGA1 protein 38
HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents 38
Akt-dependent T198 phosphorylation of cicli-dependent kinase inhibitor p27kip1 in breast cancer. 38
Noncoding RNAs in Thyroid-Follicular-Cell-Derived Carcinomas 38
Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas. 37
UBE2C is a transcriptional target of the cell cycle regulator FOXM1 37
Totale 4.970
Categoria #
all - tutte 28.496
article - articoli 25.983
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 279
Totale 54.758


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202462 0 0 0 0 0 0 0 0 13 1 40 8
2024/20253.413 18 15 309 136 673 122 89 162 132 246 813 698
2025/20265.182 255 515 546 894 1.105 206 716 259 265 249 172 0
Totale 8.657